Reaction

Infusion Site Rash reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,345 reports · 55 co-occurring drugs

As of the last recalculation, Infusion Site Rash appears in 1,345 FAERS reports alongside 55 co-occurring drug terms. The strongest observed disproportionality signal is HUMAN IMMUNOGLOBULIN G (PRR 65.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Human Immunoglobulin G	82	65.4	65.7
Diphenhydramine Hydrochloride Capsule, Liquid Filled	74	56.7	56.9
Treprostinil	332	54.0	54.2
Adrenalinum	119	48.6	48.7
Ketoprofen	39	47.3	47.5
Epinephrine	144	38.0	38.1
Diphenhydramine	135	36.6	36.7
Amitriptyline Hydrochloride	38	34.5	34.5
Lidocaine	117	33.9	34.0
Lidocaine Hydrochloride	120	33.7	33.8
Eptinezumab-Jjmr	17	29.3	29.3
Diphenhydramine Hydrochloride	246	27.9	27.9
Lidicaine	82	27.6	27.6
Burn Relief	82	27.6	27.6
Lidocaine Hydrochloride And Epinephrine	82	27.5	27.6
Lidocaine, Menthol	82	27.2	27.2
Epoprostenol	22	26.4	26.5
Lidocaine Hydrochloride And Epinephrine Bitartrate	82	25.3	25.3
Lidocaine 4%	83	25.1	25.1
Sildenafil Powder,	55	24.9	24.9
Macitentan	101	24.3	24.4
Sodium Chloride Tablet	105	23.9	23.9
Sodium Chloride Tablets	105	23.9	23.9
Riociguat	47	23.1	23.1
Sildenafil	79	22.4	22.4
Sodium Chloride	105	22.2	22.3
Tadalafil	117	19.7	19.7
Agalsidase Beta	11	18.6	18.6
Cimetidine	11	17.8	17.8
0Xygen	52	17.0	17.0
Oxygen	52	17.0	17.0
Selexipag	27	16.5	16.5
Sildenafil Citrate	123	16.4	16.4
Ambrisentan	120	16.2	16.2
Azelastine	18	15.7	15.7
Triamcinolone Acetonide Ointment Usp, 0.05%	23	15.4	15.5
Tranexamic Acid	8	14.0	14.0
Clonidine	43	13.4	13.4
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	17	12.9	12.9
Naproxen Sodium, Pseudoephedrine Hydrochloride	17	12.9	12.9
Buspirone Hydrochloride	9	12.7	12.7
Methimazole	6	11.9	11.9
Levocetirizine Dihydrochloride	18	11.7	11.7
Triamcinolone Acetonide	23	11.7	11.7
Tiotropium Bromide Inhalation Spray	8	11.1	11.1
Guaifenesin	20	10.3	10.3
Iron Sucrose	6	9.8	9.8
Bosentan	27	8.4	8.4
Fexofenadine Hydrochloride	11	7.9	7.9
Rimegepant Sulfate	5	6.1	6.1
Vibegron	3	5.8	5.8
Ravulizumab	4	4.6	4.6
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	12	4.5	4.5
Budesonide, Glycopyrrolate, And Formoterol Fumarate	3	4.5	4.5
Natalizumab	39	3.4	3.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.